Sterling

Emergent BioSolutions vs GSK vs Pfizer and 1 More Revenue Comparison

Compare financial metrics side-by-side using real SEC EDGAR data

Emergent BioSolutions logo
Emergent BioSolutions
GSK logo
GSK
Pfizer logo
Pfizer
Merck & Co. logo
Merck & Co.

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q3 2026: Emergent BioSolutions 0.11, GSK 11.109, Pfizer 16.583, Merck & Co. 18.085.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Emergent BioSolutions, GSK, Pfizer, Merck & Co..
MetricEmergent BioSolutionsGSKPfizerMerck & Co.
Market Cap$288.44M$98.70B$162.27B$353.44B
Revenue$110.00M$11.11B$16.58B$18.09B
Cost of Revenue$91.00M$2.84B$4.03B$4.89B
Gross Profit$19.00M$8.27B$12.55B$13.19B
Operating Income$-37.00M$3.21B$3.67B$5.59B
Net Income$-33.00M$1.93B$3.24B$5.07B
R&D Expense$9.00M$2.34B$3.02B$4.54B
Earnings Per Share-$0.64$0.96$0.56$2.04
Gross Margin16.9%74.5%75.7%73.0%
Operating Margin-33.9%28.9%22.1%30.9%
Net Profit Margin-29.7%17.4%19.6%28.0%
Free Cash Flow$97.00M$3.04B$4.80B$5.52B
Cumulative Free Cash Flow$720.00M$160.25B$361.51B$255.22B
Operating Cash Flow$100.00M$3.51B$5.38B$6.56B
Cash & Equivalents$176.00M$3.72B$1.82B$9.55B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites